Autoimmune, Cholestatic and Biliary Disease
The role of macrophage migration inhibitory factor in autoimmune liver disease
Version of Record online: 20 DEC 2013
© 2013 by the American Association for the Study of Liver Diseases
Volume 59, Issue 2, pages 580–591, February 2014
How to Cite
Assis, D. N., Leng, L., Du, X., Zhang, C. K., Grieb, G., Merk, M., Garcia, A. B., McCrann, C., Chapiro, J., Meinhardt, A., Mizue, Y., Nikolic-Paterson, D. J., Bernhagen, J., Kaplan, M. M., Zhao, H., Boyer, J. L. and Bucala, R. (2014), The role of macrophage migration inhibitory factor in autoimmune liver disease. Hepatology, 59: 580–591. doi: 10.1002/hep.26664
Potential conflict of interest: Dr. Bucala is a coinventor on patent applications describing the utility of MIF genotype determination.
This work was supported by the National Institutes of Health (NIH; the clinical/translational, cell and molecular biology and morphology core facilities of P30 DK34989, the Yale Liver Center), an NIH Digestive Diseases Research Core Centers (DK034989-28) Liver Center Pilot Project Award (to D.A.), an American Liver Foundation Postdoctoral Autoimmune Hepatitis Grant (to D.A.), NIH T32 DK007356-33 (to D.A.), the German Research Foundation (DFG; BE1977/4-2 and SFB/TRR57-P07; to J.B.), NIH DK25636 (to J.L.B.), NIH AR050498 and AR049610 (to R.B.), and N01-HHSN272201100019C (to R.B.).
- Issue online: 29 JAN 2014
- Version of Record online: 20 DEC 2013
- Accepted manuscript online: 2 AUG 2013 06:46AM EST
- Manuscript Accepted: 28 JUL 2013
- Manuscript Received: 4 DEC 2012
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.